The Company is developing Teverelix® as a best-in-class market product for advanced prostate cancer patients with high CV risk and a first in class product for Acute Urinary Retention Relapse preventi ...
The COVID-19 pandemic highlighted an urgent need for efficient, durable, and widely accessible vaccines. This prompted several important innovations in vaccine technology, and researchers continue to ...
DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ -- Dubai Science Park, the Middle East's leading science-focused hub, is celebrating two decades of enabling science and nurturing the region's research and ...
Vietnam Investment Review on MSN
Huawei Plans Madrid Product Launch Event
MADRID, Feb. 4, 2026 /PRNewswire/ -- Huawei is thrilled to announce the upcoming HUAWEI Innovative Product Launch in Madrid, Spain, set to take place on February 26, 2026. At the heart of this event ...
Relay Therapeutics gets US FDA Breakthrough Therapy Designation for zovegalisib to treat advanced breast cancer: Cambridge, Massachusetts Thursday, February 5, 2026, 16:00 Hrs [IS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results